Clinical Neurology and Neuroscience

Special Issue

Muscular Dystrophy

  • Submission Deadline: 15 May 2020
  • Status: Submission Closed
  • Lead Guest Editor: Maria Sofia Cotelli
About This Special Issue
Muscular dystrophy (MD) is a group of muscle diseases that results in increasing weakening and breakdown of skeletal muscles over time. The disorders differ in which muscles are primarily affected, the degree of weakness, how fast they worsen, and when symptoms begin. In many cases affected patients are convicted to wheelchair. Most important complicances involve heart and respiratory systems.
Muscular dystrophy group involves many different genetic disorders that are usually classified into main categories. The most common type is Duchenne muscular dystrophy (DMD), which typically affects males beginning around the age of four. Other types include Becker muscular dystrophy, facioscapulohumeral muscular dystrophy, and myotonic dystrophy. They are due to mutations in genes that are involved in producing and regulating muscle proteins. Inheritance can be Disorders may be X-linked recessive, autosomal recessive or autosomal dominant. Diagnosis often involves blood tests and genetic testing.
Aims and Scope:
  1. Muscular
  2. Dystrophy
  3. Respiratory
  4. Cardiological
  5. Emergency
  6. Rehabilitation
Lead Guest Editor
  • Maria Sofia Cotelli

    Neurology Unit, Azienda Socio Sanitaria Territoriale Valcamonica, Esine, Italy

Guest Editors
  • Marinella Turla

    Neurology Unit, Azienda Socio Sanitaria Territoriale Valcamonica, Esine, Italy

  • Patrizia Civelli

    Asst Valcamonica-Esine, Brescia, Italy

  • DAMIANO BOTTONE

    Asst Valcamonica- Esine, Esine, Italy

  • Luisa Salada

    Pneumology Unit, Azienda Socio Sanitaria Territoriale Valcamonica, Esine, Italy

  • Filippo Manelli

    Emergency Unit, Azienda Socio Sanitaria Territoriale Valcamonica, Esine, Italy

  • Roberto Furloni

    Medicine Unit, Azienda Socio Sanitaria Territoriale Valcamonica, Esine, Italy